These results validate the molecular mechanisms whereby HPK1 mediates proinflammatory responses and NET formation in neutrophils and suggest that i-HPK1 treatment ameliorates acute lung injury after ischemic stroke. Here, MAP4K1 is linked to ischemic stroke.